Bronchodilation and symptom improvement with ensifentrine, a dual pde3/4 inhibitor: Sub-group analyses of a four week randomized, controlled trial in patients with COPD

Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2020
This article has no abstract
Epistemonikos ID: 577c865e4fd7d22876415698d0306b3fe729ea10
First added on: Feb 11, 2025